324 related articles for article (PubMed ID: 33300880)
21. Randomized Controlled Trials for the Treatment of Hidradenitis Suppurativa.
van Rappard DC; Mekkes JR; Tzellos T
Dermatol Clin; 2016 Jan; 34(1):69-80. PubMed ID: 26617360
[TBL] [Abstract][Full Text] [Related]
22. Prospective controlled clinical and histopathologic study of hidradenitis suppurativa treated with the long-pulsed neodymium:yttrium-aluminium-garnet laser.
Mahmoud BH; Tierney E; Hexsel CL; Pui J; Ozog DM; Hamzavi IH
J Am Acad Dermatol; 2010 Apr; 62(4):637-45. PubMed ID: 20227579
[TBL] [Abstract][Full Text] [Related]
23. Evidence-based approach to the treatment of hidradenitis suppurativa/acne inversa, based on the European guidelines for hidradenitis suppurativa.
Gulliver W; Zouboulis CC; Prens E; Jemec GB; Tzellos T
Rev Endocr Metab Disord; 2016 Sep; 17(3):343-351. PubMed ID: 26831295
[TBL] [Abstract][Full Text] [Related]
24. A Novel Severity Assessment Scoring System for Hidradenitis Suppurativa.
Hessam S; Scholl L; Sand M; Schmitz L; Reitenbach S; Bechara FG
JAMA Dermatol; 2018 Mar; 154(3):330-335. PubMed ID: 29417136
[TBL] [Abstract][Full Text] [Related]
25. [Topical and novel device-based therapies for mild hidradenitis suppurativa].
Nikolakis G; von Stebut E
Hautarzt; 2021 Aug; 72(8):676-685. PubMed ID: 34223936
[TBL] [Abstract][Full Text] [Related]
26. [Hidradenitis suppurativa/acne inversa in daily practice].
Kurzen H; Fritz K; Altenburg A
Hautarzt; 2021 Aug; 72(8):706-714. PubMed ID: 34223937
[TBL] [Abstract][Full Text] [Related]
27. Clinical response rate and flares of hidradenitis suppurativa in the treatment with adalimumab.
Caposiena Caro RD; Cannizzaro MV; Tartaglia C; Bianchi L
Clin Exp Dermatol; 2020 Jun; 45(4):438-444. PubMed ID: 31630436
[TBL] [Abstract][Full Text] [Related]
28. Major gaps in understanding and treatment of hidradenitis suppurativa.
Hoffman LK; Ghias MH; Garg A; Hamzavi IH; Alavi A; Lowes MA
Semin Cutan Med Surg; 2017 Jun; 36(2):86-92. PubMed ID: 28538750
[TBL] [Abstract][Full Text] [Related]
29. Staphylococcus aureus Carriage in Hidradenitis Suppurativa: Impact on Response to Adalimumab.
Stergianou D; Tzanetakou V; Argyropoulou M; Kanni T; Bagos PG; Giamarellos-Bourboulis EJ
Dermatology; 2021; 237(3):372-377. PubMed ID: 33401280
[TBL] [Abstract][Full Text] [Related]
30. [Hidradenitis suppurativa/acne inversa: An update].
Kirschke J; Hessam S; Bechara FG
Hautarzt; 2015 Jun; 66(6):413-22. PubMed ID: 25877488
[TBL] [Abstract][Full Text] [Related]
31. Real-world safety and effectiveness of adalimumab in patients with hidradenitis suppurativa: 12-week interim analysis of post-marketing surveillance in Japan.
Hayashi N; Hayama K; Takahashi K; Kurokawa I; Okazaki M; Kashiwagi T; Iwashita E; Terui T
J Dermatol; 2022 Apr; 49(4):411-421. PubMed ID: 35040156
[TBL] [Abstract][Full Text] [Related]
32. Long-Wave Medical Infrared Thermography: A Clinical Biomarker of Inflammation in Hidradenitis Suppurativa/Acne Inversa.
Zouboulis CC; Nogueira da Costa A; Jemec GBE; Trebing D
Dermatology; 2019; 235(2):144-149. PubMed ID: 30650424
[TBL] [Abstract][Full Text] [Related]
33. Hidradenitis Suppurativa.
Jenkins T; Isaac J; Edwards A; Okoye GA
Dermatol Clin; 2023 Jul; 41(3):471-479. PubMed ID: 37236715
[TBL] [Abstract][Full Text] [Related]
34. Clinical response rates, placebo response rates, and significantly associated covariates are dependent on choice of outcome measure in hidradenitis suppurativa: A post hoc analysis of PIONEER 1 and 2 individual patient data.
Frew JW; Jiang CS; Singh N; Grand D; Navrazhina K; Vaughan R; Krueger JG
J Am Acad Dermatol; 2020 May; 82(5):1150-1157. PubMed ID: 31881294
[TBL] [Abstract][Full Text] [Related]
35. Systematic Review of Light-Based Treatments for Hidradenitis Suppurativa.
Gracia Cazaña T; Berdel Díaz LV; Martín Sánchez JI; Querol Nasarre I; Gilaberte Y
Actas Dermosifiliogr (Engl Ed); 2020 Mar; 111(2):89-106. PubMed ID: 31870491
[TBL] [Abstract][Full Text] [Related]
36. Guselkumab for hidradenitis suppurativa: a phase II, open-label, mode-of-action study.
Dudink K; Bouwman K; Chen Y; DePrimo SE; Munoz-Elias EJ; Aarts P; Schappin R; Florencia EF; van Heeswijk B; Prens LM; van der Zee HH; Prens EP; van Straalen KR; Horváth B
Br J Dermatol; 2023 Apr; 188(5):601-609. PubMed ID: 36811949
[TBL] [Abstract][Full Text] [Related]
37. [Impact of LAight therapy on hidradenitis suppurativa care].
Zimmer S; Basien K; von Stebut E
Hautarzt; 2021 Jul; 72(7):586-594. PubMed ID: 34125251
[TBL] [Abstract][Full Text] [Related]
38. Non-surgical treatment of hidradenitis suppurativa: the role of cryotherapy.
Dell'Antonia M; Anedda J; Tatti A; Falco A; Sanna S; Ferreli C; Atzori L
Front Med (Lausanne); 2023; 10():1141691. PubMed ID: 37144039
[TBL] [Abstract][Full Text] [Related]
39. Hidradenitis suppurativa.
González-López MA
Med Clin (Barc); 2024 Feb; 162(4):182-189. PubMed ID: 37968174
[TBL] [Abstract][Full Text] [Related]
40. Treatment of hidradenitis suppurativa by photodynamic therapy with aminolevulinic acid: preliminary results.
Schweiger ES; Riddle CC; Aires DJ
J Drugs Dermatol; 2011 Apr; 10(4):381-6. PubMed ID: 21455548
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
